REG - Mast Energy Dvlpmts. - Capitalisation of Loan Update

Mast Energy DevelopmentsAnnouncement

23/05/2024 16:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240523:nRSW7171Pa&default-theme=true

RNS Number : 7171P  Mast Energy Developments PLC  23 May 2024

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

LEI :213800HFVHGJ9YGO9F71

Share code on the LSE: MAST

ISIN: GB00BMBSCV12

('MED' or 'the Company')

 

Dated: 23 May 2024

 

Mast Energy Developments PLC ('MED' or 'the Company')

 

Capitalisation of Loan Update

 

Mast Energy Developments PLC, the UK-based multi-asset owner, developer and
operator in the rapidly growing flexible power market, is pleased to announce
that further to its RNS announcement of 7 May 2024, the 162,500,000 new MED
ordinary shares of 0.1p (the "Subscription Shares") at a conversion price of
0.20p per share will be allotted to Mr. Pieter Krügel, a director of the
Company (the "Conversion") tomorrow, 24 May 2024 and admitted to listing on
the London Stock Exchange for which approval has been granted (the
"Admission").

 

 

Total Voting Rights

 

Following allotment of the Subscription Shares and Admission, the Company will
have  426,354,067 ordinary shares of £0.001 par value in issue, each with
one vote per share (and none of which are held in treasury). The total number
of voting rights in the Company is therefore 426,354,067. This figure  may be
used by shareholders in the Company as the denominator for calculations to
determine if they have a notifiable interest in the share capital of the
Company under the Disclosure Guidance and Transparency Rules, or if such
interest has
changed. For further information, please visit www.med.energy
(http://www.med.energy/) .

 

ENDS

 

This announcement contains inside information for the purposes of the UK
version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of
United Kingdom domestic law by virtue of the European Union (Withdrawal) Act
2018 ('UK MAR'). Upon the publication of this announcement, this inside
information is now considered to be in the public domain.

 

For further information please visit www.med.energy (http://www.med.energy/)
or contact:

 Pieter Krügel   info@med.energy (mailto:info@med.energy)  Mast Energy        CEO

                                                           Developments PLC
 Jon Belliss     +44 (0)20 7399 9425                       Novum Securities   Corporate Broker

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDEALSDAFDLEFA